Rick Simpson Oil (RSO): What the Research Actually Says

Few medical marijuana products carry as much mythology as Rick Simpson Oil. Named after the Canadian engineer who popularized it in the early 2000s after claiming it cured his skin cancer, RSO has become one of the most discussed — and most controversial — products in the medical marijuana world.

Supporters point to thousands of testimonials and a handful of preclinical studies showing cannabinoids can kill cancer cells. Critics point out the absence of clinical trials proving RSO cures cancer in humans, and the danger of patients abandoning proven treatments based on unverified claims.

The truth, as usual, is more complicated than either camp acknowledges. RSO is a real, potent medical marijuana product with legitimate therapeutic applications. But the claims surrounding it often outpace the evidence. Here's what the research actually shows.

What RSO Actually Is

Rick Simpson Oil is a full-extract cannabis oil (FECO) — a concentrated, whole-plant extract that retains the full spectrum of cannabinoids, terpenes, flavonoids, and other compounds present in the source plant. Unlike isolated THC or CBD products, RSO preserves the chemical complexity of the original plant material in a highly concentrated form.

Key characteristics:

• Very high THC content. Typical RSO contains 60-90% THC by weight, making it one of the most potent medical marijuana products available. A single rice-grain-sized dose may contain 25-50mg of THC — a substantial amount.
• Full-spectrum profile. RSO contains not just THC but also CBD, CBN, CBG, CBC, terpenes, and other plant compounds. This distinguishes it from distillate products that may be equally potent in THC but lack the broader chemical profile.
• Oral/sublingual administration. RSO is typically taken orally — placed on food, swallowed in a capsule, or absorbed under the tongue. It's not intended for smoking or vaping.
• Dark, viscous appearance. The thick, dark-colored oil is visually distinctive — a result of the full-spectrum extraction process retaining chlorophyll, waxes, and other plant components that more refined products remove.

Manufacturing considerations: RSO is traditionally made using a solvent extraction process (originally with naphtha, now more commonly with ethanol or isopropanol). The quality and safety of the final product depend heavily on the extraction process — complete solvent removal is critical. Products purchased from licensed dispensaries in regulated state programs undergo testing for residual solvents. Homemade RSO, which Rick Simpson originally advocated, carries real risks of solvent contamination.

The Cancer Claims: Separating Lab Data from Clinical Evidence

The most prominent claim about RSO is that it cures cancer. Rick Simpson's original story — applying the oil topically to basal cell carcinoma lesions that subsequently resolved — has been amplified by thousands of similar testimonials. But testimonials aren't clinical evidence, and the scientific picture is more nuanced.

What the preclinical research shows:

There is genuine, published research demonstrating that cannabinoids — particularly THC — can kill cancer cells in laboratory settings. This isn't fabricated or fringe science. It comes from major research institutions and appears in peer-reviewed journals.

A 2006 pilot study by Guzman et al. in British Journal of Cancer administered THC directly into the tumors of 9 patients with recurrent glioblastoma (an aggressive brain cancer). While the study was primarily designed to assess safety, two of the nine patients showed decreased tumor cell proliferation. The study demonstrated that intratumoral THC was safe and that further research was warranted.

A 2014 study in Molecular Cancer Therapeutics found that THC and CBD, used in combination with temozolomide (standard chemotherapy for brain cancer), produced more potent anticancer effects than any single agent alone — in cell cultures and animal models.

A 2018 review in Cancers systematically examined preclinical studies of cannabinoids against various cancer types and found anticancer activity demonstrated against glioma, breast cancer, lung cancer, prostate cancer, colorectal cancer, and leukemia — in cell lines and animal models. The mechanisms included:

• Induction of apoptosis (programmed cell death) in cancer cells
• Inhibition of tumor angiogenesis (blood vessel formation that feeds tumors)
• Reduction of cancer cell migration and invasion (metastasis potential)
• Modulation of the immune response against tumors

The critical gap: All of this work is preclinical — cells in dishes and tumors in mice. The history of oncology is filled with compounds that killed cancer cells in the lab but failed to work in human patients. The biological complexity of cancer in a living person — tumor heterogeneity, immune evasion, drug distribution and metabolism, resistance mechanisms — creates hurdles that lab studies can't predict.

As of 2026, no randomized controlled trial has demonstrated that RSO or any other medical marijuana product produces tumor regression, extends survival, or cures cancer in human patients when used as a primary or standalone treatment.

Case reports that are interesting but not conclusive:

Several published case reports describe tumor responses in patients using medical marijuana concentrates:

• A 2019 case report in Cureus described a lung cancer patient who refused conventional treatment and used CBD oil — the tumor appeared to shrink on follow-up imaging. But case reports cannot establish causation (spontaneous tumor regression, though rare, does occur).
• Other case reports have described similar observations, but without controlled conditions, it's impossible to know whether the medical marijuana caused the improvement, contributed to it, or coincided with it.

What RSO Can Legitimately Help With

Setting aside the unproven cancer cure claims, RSO has legitimate applications based on the same evidence that supports other medical marijuana products — but at higher potency:

Severe chronic pain: RSO's high THC concentration makes it useful for patients with pain that doesn't respond to lower-potency products. The oral route provides long-lasting effects (4-8 hours), which is advantageous for overnight pain management. Cancer pain, neuropathic pain, and severe arthritis pain are common indications.

Chemotherapy side effects: Nausea, vomiting, appetite loss, and insomnia during cancer treatment are well-established applications for THC-based medical marijuana. RSO's potency means small doses can produce significant antiemetic and appetite-stimulating effects.

Severe insomnia: For patients with treatment-resistant insomnia — particularly when pain or anxiety is a contributing factor — RSO's sedating properties at appropriate doses can be effective. The long duration of oral THC means effects persist through the night.

Palliative care: In end-of-life care, quality of life is the primary goal. RSO can address multiple symptoms simultaneously — pain, appetite loss, nausea, anxiety, insomnia — which is valuable when patients are already taking numerous medications for individual symptoms.

Spasticity: Patients with MS, spinal cord injuries, or other conditions causing severe muscle spasticity may benefit from RSO's muscle-relaxant properties at doses achievable with this concentration.

The Rick Simpson Protocol: What It Claims and Why Physicians Are Cautious

Rick Simpson's original protocol calls for gradually escalating doses over a 90-day period, eventually reaching 1 gram of RSO per day — which can mean 600-900mg of THC daily. This is an enormous dose by any clinical standard.

The protocol was designed with the assumption that high-dose THC directly kills cancer cells, and that the necessary blood concentrations can only be achieved with very large oral doses. The claim is that tolerance develops rapidly enough to make these doses tolerable.

Why physicians are cautious:

• No clinical trial has validated this dosing protocol. The doses Simpson recommends far exceed anything studied in human clinical trials.
• Side effects at high doses are real. Even with tolerance, 600-900mg of THC daily produces significant psychoactive effects, sedation, cognitive impairment, and potential cardiovascular strain (tachycardia, blood pressure fluctuations). For elderly patients or those with heart disease, these effects carry real risk.
• Opportunity cost. The greatest danger of the RSO cancer protocol isn't the oil itself — it's the potential for patients to delay or refuse evidence-based cancer treatment while pursuing an unproven approach. A delay of weeks or months in treating aggressive cancers can be the difference between a curable and incurable stage.
• The protocol wasn't designed by a physician or researcher. Rick Simpson is an engineer, not a medical professional. His personal experience, while genuine to him, doesn't constitute medical evidence.

How to Think About RSO Rationally

Here's a balanced framework:

RSO as symptom management — evidence-based. Using RSO for pain, nausea, appetite loss, insomnia, and quality of life improvement is supported by the same evidence base that supports other THC-containing medical marijuana products. The concentration is higher, which means smaller volumes are needed, but the pharmacology is the same.

RSO as cancer treatment — not proven. The preclinical data is intriguing and warrants further clinical research. But using RSO as a replacement for surgery, chemotherapy, radiation, or immunotherapy is not supported by clinical evidence and carries the risk of disease progression during the delay.

RSO as complementary to cancer treatment — reasonable. Using RSO alongside conventional cancer treatment to manage symptoms and improve quality of life is a clinically reasonable approach. Some preclinical data even suggests cannabinoids may enhance the effectiveness of certain chemotherapy drugs — though this hasn't been confirmed in clinical trials.

Quality matters. If you're going to use RSO, get it from a licensed dispensary where it's been tested for potency, residual solvents, pesticides, and contaminants. Homemade RSO, while historically popular, introduces unnecessary safety risks.

Dosing RSO: Why "Start Low, Go Slow" Matters Even More

Because RSO is so concentrated, dosing errors have outsized consequences. Taking too much THC is not dangerous in the way that taking too many opioids is dangerous (cannabinoid overdose is not fatal), but it can produce several hours of extremely uncomfortable effects — severe anxiety, paranoia, dissociation, nausea, rapid heart rate, and disorientation.

A reasonable initiation protocol:

• Days 1-7: Start with a rice-grain-sized amount (approximately 10-25mg THC depending on concentration) once daily, preferably in the evening.
• Days 8-14: If tolerated, increase to the same amount twice daily.
• Weeks 3-4: Gradually increase the per-dose amount based on tolerability and symptom response.
• Ongoing: Adjust based on symptom management goals. Most patients settle at a dose well below the 1g/day Simpson protocol, finding adequate symptom relief at moderate doses.

Important: Do not attempt the full Simpson protocol (1g/day) without physician guidance. The doses are extreme, and the purported cancer-curing benefit hasn't been demonstrated in clinical trials.

Having the RSO Conversation With Your Doctor

If you're interested in RSO, the best approach is an honest conversation with a physician who understands medical marijuana — not just the certifying process, but the pharmacology and the evidence.

At CORAL, Dr. Kim discusses RSO with patients who ask about it — including what the research supports, what it doesn't, and how to use it safely for symptom management. The conversation is evidence-based, not dismissive. The preclinical data on cannabinoids and cancer is real science that deserves serious attention and continued research. But responsible medical practice requires distinguishing between what's been demonstrated and what's been hoped for.

If you're considering medical marijuana — whether RSO specifically or other formulations — you can start the evaluation process at [coral.clinic/start](https://coral.clinic/start). The goal is always to match the product and approach to your actual medical needs, grounded in what the evidence supports.